Changes in Beneficial Ownership · 4
Viatris Inc.
VTRSNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
form4.xml
Filing details
- Report period
- 2026-09-30
- Issuer
- Viatris Inc
- Issuer CIK
- 0001792044
- Trading symbol
- VTRS
Reporting owner 1
- Name
- SIMMONS DAVID S
- Reporting owner CIK
- 0001508519
- Relationship
- Director
- Address
- 1000 MYLAN BOULEVARD, CANONSBURG, PA, 15317
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock Units | [F1] | 2026-09-30 | A · Form 4 | 2,117 | A | 17.72 | [F1] | [F1] | Common Stock | 2,117 | 4,479 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Derivative holdings
| Security | Conversion / exercise price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Amount owned | Ownership |
|---|---|---|---|---|---|---|---|
| Dividend Equivalent DSUs[F2] | [F2] | [F2] | [F2] | Common Stock | 16.6533[F2] | 16.6533[F2] | D |
Table key
- D
- Direct
Footnotes
- F1
- On September 30, 2026, the reporting person was automatically granted 2,117 deferred stock units (DSUs) pursuant to the reporting person's election to receive payment of quarterly non-employee director fees in the form of DSUs. This grant was made in lieu of cash fees, based on the September 30, 2026 closing price of $17.72 per share of common stock of Viatris Inc. (Viatris). Each DSU is fully vested and represents the right to receive one share of common stock of Viatris. The DSUs settle in shares of common stock upon the earliest of the reporting person's termination of service as a non-employee director, the reporting person's death or disability, or a change in control.↩ 1↩ 2↩ 3
- F2
- Represents dividend equivalent DSUs that accrued with respect to DSUs previously granted to the reporting person with respect to the election to receive payment of quarterly director fees in the form of DSUs and vest on the same schedule as the underlying DSUs. Amount represents dividend equivalent DSUs that accrued with respect to such DSUs in transactions exempt from Section 16 under Rule 16a-11.↩ 1↩ 2↩ 3↩ 4↩ 5↩ 6
Signature 1
- Signed
- /s/ Kevin Macikowski, by power of attorney
- Date
- 2026-10-02
Company context
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life. We meet the needs of patients around the world by acting decisively with ingenuity and resolve. Whether we’re developing new medicines, working to maintain a resilient supply of needed therapies, or pursuing bold innovation, we strive to deliver solutions that are effective at scale and built to endure. We’re purpose-built to make an impact with a broad portfolio that spans generics, value-added medicines, established brands and innovative medicines that address areas of significant unmet need. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X.
Current securities
Recent company filings
- SC TO-C - filed by Viatris Inc regarding Pacira BioSciences, Inc.Oct 8, 2026
- SC TO-C - filed by Viatris Inc regarding Pacira BioSciences, Inc.Oct 8, 2026
- Entry into a Material Definitive Agreement · Other EventsOct 8, 2026
- 10-Q filingAug 6, 2026
- Results of Operations and Financial Condition · Other EventsAug 6, 2026